Effects of pegylated interferon/ribavirin on bone turnover markers in HIV/Hepatitis C virus-coinfected patients

Roger Bedimo, Minhee Kang, Pablo Tebas, Edgar T. Overton, Kimberly Hollabaugh, Grace Mccomsey, Debika Bhattacharya, Christopher Evans, Todd T. Brown, Babafemi Taiwo

Research output: Contribution to journalArticle

4 Citations (Scopus)

Abstract

HIV/hepatitis C virus (HCV) patients have a 3-fold increased fracture incidence compared to uninfected patients. The impact of HCV therapy on bone health is unclear. We evaluated bone turnover markers (BTM) in well-controlled (HIV RNA

Original languageEnglish (US)
Pages (from-to)325-328
Number of pages4
JournalAIDS Research and Human Retroviruses
Volume32
Issue number4
DOIs
StatePublished - Apr 1 2016

Fingerprint

Bone Remodeling
Ribavirin
Hepacivirus
Interferons
HIV
RNA
Bone and Bones
Incidence
Health
Therapeutics

ASJC Scopus subject areas

  • Immunology
  • Virology
  • Infectious Diseases

Cite this

Effects of pegylated interferon/ribavirin on bone turnover markers in HIV/Hepatitis C virus-coinfected patients. / Bedimo, Roger; Kang, Minhee; Tebas, Pablo; Overton, Edgar T.; Hollabaugh, Kimberly; Mccomsey, Grace; Bhattacharya, Debika; Evans, Christopher; Brown, Todd T.; Taiwo, Babafemi.

In: AIDS Research and Human Retroviruses, Vol. 32, No. 4, 01.04.2016, p. 325-328.

Research output: Contribution to journalArticle

Bedimo, R, Kang, M, Tebas, P, Overton, ET, Hollabaugh, K, Mccomsey, G, Bhattacharya, D, Evans, C, Brown, TT & Taiwo, B 2016, 'Effects of pegylated interferon/ribavirin on bone turnover markers in HIV/Hepatitis C virus-coinfected patients', AIDS Research and Human Retroviruses, vol. 32, no. 4, pp. 325-328. https://doi.org/10.1089/aid.2015.0204
Bedimo, Roger ; Kang, Minhee ; Tebas, Pablo ; Overton, Edgar T. ; Hollabaugh, Kimberly ; Mccomsey, Grace ; Bhattacharya, Debika ; Evans, Christopher ; Brown, Todd T. ; Taiwo, Babafemi. / Effects of pegylated interferon/ribavirin on bone turnover markers in HIV/Hepatitis C virus-coinfected patients. In: AIDS Research and Human Retroviruses. 2016 ; Vol. 32, No. 4. pp. 325-328.
@article{0c125d784edb46ba91ce8c933dbed880,
title = "Effects of pegylated interferon/ribavirin on bone turnover markers in HIV/Hepatitis C virus-coinfected patients",
abstract = "HIV/hepatitis C virus (HCV) patients have a 3-fold increased fracture incidence compared to uninfected patients. The impact of HCV therapy on bone health is unclear. We evaluated bone turnover markers (BTM) in well-controlled (HIV RNA",
author = "Roger Bedimo and Minhee Kang and Pablo Tebas and Overton, {Edgar T.} and Kimberly Hollabaugh and Grace Mccomsey and Debika Bhattacharya and Christopher Evans and Brown, {Todd T.} and Babafemi Taiwo",
year = "2016",
month = "4",
day = "1",
doi = "10.1089/aid.2015.0204",
language = "English (US)",
volume = "32",
pages = "325--328",
journal = "AIDS Research and Human Retroviruses",
issn = "0889-2229",
publisher = "Mary Ann Liebert Inc.",
number = "4",

}

TY - JOUR

T1 - Effects of pegylated interferon/ribavirin on bone turnover markers in HIV/Hepatitis C virus-coinfected patients

AU - Bedimo, Roger

AU - Kang, Minhee

AU - Tebas, Pablo

AU - Overton, Edgar T.

AU - Hollabaugh, Kimberly

AU - Mccomsey, Grace

AU - Bhattacharya, Debika

AU - Evans, Christopher

AU - Brown, Todd T.

AU - Taiwo, Babafemi

PY - 2016/4/1

Y1 - 2016/4/1

N2 - HIV/hepatitis C virus (HCV) patients have a 3-fold increased fracture incidence compared to uninfected patients. The impact of HCV therapy on bone health is unclear. We evaluated bone turnover markers (BTM) in well-controlled (HIV RNA

AB - HIV/hepatitis C virus (HCV) patients have a 3-fold increased fracture incidence compared to uninfected patients. The impact of HCV therapy on bone health is unclear. We evaluated bone turnover markers (BTM) in well-controlled (HIV RNA

UR - http://www.scopus.com/inward/record.url?scp=84962468945&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=84962468945&partnerID=8YFLogxK

U2 - 10.1089/aid.2015.0204

DO - 10.1089/aid.2015.0204

M3 - Article

C2 - 26499270

AN - SCOPUS:84962468945

VL - 32

SP - 325

EP - 328

JO - AIDS Research and Human Retroviruses

JF - AIDS Research and Human Retroviruses

SN - 0889-2229

IS - 4

ER -